Literature DB >> 9326200

Clonal stability in late-relapsing childhood lymphoblastic leukaemia.

L Frost1, A Goodeve, G Wilson, I Peake, H Barker, A Vora.   

Abstract

We report stability of a clonal immunoglobulin heavy chain (IgH) gene rearrangement in a case of childhood acute lymphoblastic leukaemia (ALL) relapsing 17 years after completion of first-line therapy. Clonal stability was shown by polymerase chain reaction amplification of the hypervariable CDRIII region of IgH gene. Identically sized products from the original diagnostic and the second presentation samples were obtained and direct sequencing confirmed complete sequence homology. Absence of clonal evolution together with recent reports of persistent minimal residual disease in patients in long-term complete remission, suggests that 'cure' of childhood ALL may be critically dependent on effective immune surveillance to keep such disease below clinically significant levels.

Entities:  

Mesh:

Year:  1997        PMID: 9326200     DOI: 10.1046/j.1365-2141.1997.3103129.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blasts.

Authors:  Fumio Bessho; Nobuyuki Takayama; Eva Fronkova; Jan Zuna
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

2.  Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.

Authors:  Jean-François Spinella; Chantal Richer; Pauline Cassart; Manon Ouimet; Jasmine Healy; Daniel Sinnett
Journal:  Blood Adv       Date:  2018-02-13

3.  Protracted dormancy of pre-leukemic stem cells.

Authors:  A M Ford; M B Mansur; C L Furness; F W van Delft; J Okamura; T Suzuki; H Kobayashi; Y Kaneko; M Greaves
Journal:  Leukemia       Date:  2015-05-28       Impact factor: 11.528

4.  Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.

Authors:  Ling Xu; Jianyu Weng; Xin Huang; Chengwu Zeng; Shaohua Chen; Suxia Geng; Lijian Yang; Suijing Wu; Suming Huang; Xin Du; Yangqiu Li
Journal:  Oncotarget       Date:  2016-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.